Feature | Coronavirus (COVID-19) | February 28, 2020

Significant overlap in COVID-19, SARS and MERS in CT imaging according to new American Journal of Roentgenology article 

A chest CT scan of a 79-year-old woman who presented with fever, dry cough, and chest pain for three days. Her husband and daughter-in-law had been recently diagnosed with coronavirus disease. The patient expired 11 days after admission.(Courtesy of Song F, Shanghai Public Health Clinical Center, Shanghai, China) #COVID2019 #COVID19 #coronavirus #2019nCoV

A chest CT scan of a 79-year-old woman who presented with fever, dry cough, and chest pain for three days. Her husband and daughter-in-law had been recently diagnosed with coronavirus disease. The patient expired 11 days after admission.(Courtesy of Song F, Shanghai Public Health Clinical Center, Shanghai, China)


February 28, 2020 — The first in a series of medical imaging studies on novel coronavirus (COVID-19) was published online ahead of print this week by the American Journal of Roentgenology (AJR). The article "Radiology Perspective Of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome And Middle East Respiratory Syndrome," shows that despite COVID-19’s imaging features are variable and nonspecific, the findings reported thus far do show “significant overlap” with those of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).[1]

The article was based on a review of the present clinical literature concerning COVID-19. Unlike SARS and MERS, where initial chest imaging abnormalities are more frequently unilateral, COVID-19 is more likely to involve both lungs on initial imaging.

“Early evidence suggests that initial chest imaging will show abnormality in at least 85 percent of patients, with 75 percent of patients having bilateral lung involvement initially that most often manifests as sub-pleural and peripheral areas of ground-glass opacity and consolidation,” said lead study author Melina Hosseiny, M.D., a University of California at Los Angeles (UCLA) radiologist. She added older age and progressive consolidation may also imply an overall poorer prognosis.

47-year-old Chinese man with 2-day history of fever, chills, productive cough, sneezing, and fatigue who presented to emergency department. A and B, Initial CT images obtained show small round areas of mixed ground-glass opacity and consolidation (rectangles) at level of aortic arch (A) and ventricles (B) in right and left lower lobe posterior zones. C and D, Follow-up CT images obtained 2 days later show progression of abnormalities (rectangles) at level of aortic arch (C) and ventricles (D), which now involve right upper and right and left lower lobe posterior zones. #Coronavirus #COVID19 #2019nCoV

A 47-year-old Chinese man with two-day history of fever, chills, productive cough, sneezing, and fatigue who presented to emergency department. A and B, Initial CT images obtained show small round areas of mixed ground-glass opacity and consolidation (rectangles) at level of aortic arch (A) and ventricles (B) in right and left lower lobe posterior zones. C and D, Follow-up CT images obtained 2 days later show progression of abnormalities (rectangles) at level of aortic arch (C) and ventricles (D), which now involve right upper and right and left lower lobe posterior zones. Image courtesy of AJR.

 

Since the outbreak of the novel coronavirus in China, more than 82,000 people have contracted the virus and killed 2,800 worldwide.[2] The virus is rapidly spreading with human-to-human transmission despite imposed precautions. Because similar pulmonary syndromes have been reported from other strains of the coronavirus family, the researchers for this study wanted to review  the lessons from previous SARS and MERS imaging studies.

COVID-19 is diagnosed on the presence of pneumonia symptoms (including dry cough, fatigue, myalgia, fever and dyspnea), as well as recent travel to China or known exposure, and chest imaging plays a vital role in both assessment of disease extent and follow-up. Unlike SARS and MERS — where initial chest imaging abnormalities are more frequently unilateral — COVID-19 is more likely to involve both lungs on initial computed tomography (CT) imaging.

“To our knowledge,” the study authors wrote, "pleural effusion, cavitation, pulmonary nodules and lymphadenopathy have not been reported in patients with COVID-19.” Ultimately, the authors of this AJR article recommended CT for follow-up in patients recovering from COVID-19 to evaluate long-term or even permanent pulmonary damage, including fibrosis — as seen in SARS and MERS infections.  

A comparison of clinical and radiologic features of SARS, MERS and COVID-19 CT imaging from the article in AJR. #Coronavirus #COVID19 #2019nCoV

A comparison of clinical and radiologic features of SARS, MERS and COVID-19 CT imaging from the article in AJR.

 

Related Coronavirus Content:

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Emerging Technologies Proving Value in Chinese Coronavirus Fight

The Cardiac Implications of Novel Coronavirus

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Infervision in the Frontlines Against the Coronavirus

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

FDA Resource on the Novel coronavirus (COVID-19)

Mount Sinai Physicians the First in U.S. Analyzing Lung Disease in Coronavirus Patients from China

References:

1. Melina Hosseiny, Soheil Kooraki, Ali Gholamrezanezhad, et al. Radiology Perspective Of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome And Middle East Respiratory Syndrome. American Journal of Roentgenology. 1-5. 10.2214/AJR.20.22969. Published online Feb 2020.

2. World Health Organization (WHOE) Coronavirus disease 2019 (COVID-19) Situation Report – 38. Feb 27, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200227-sitrep-38-covid-19.pdf?sfvrsn=9f98940c_2.

 


Related Content

News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...

Time April 23, 2024
arrow
News | FDA

April 23, 2024 — Royal Philips , a global leader in health technology, today announced its Philips Zenition 30 mobile C ...

Time April 23, 2024
arrow
News | Ultrasound Imaging

April 22, 2024 — GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which ...

Time April 22, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
News | ACR

April 15, 2023 — The American College of Radiology (ACR) released an update to its ACR Appropriateness Criteria (ACR AC) ...

Time April 13, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
Subscribe Now